EpiMix is an integrative tool for epigenomic subtyping using DNA methylation

Area of Science:

• Epigenetics
• Genomics
• Computational Biology

Background:

• DNA methylation (DNAme) is a crucial epigenetic regulator of gene expression.
• Aberrant DNAme is implicated in various diseases, including cancer, immunological, and cardiovascular conditions.
• Genome-wide DNAme profiling in large human cohorts is now feasible, necessitating advanced analytical tools.

Purpose of the Study:

• To develop a sensitive analytical framework for population-level DNA methylation analysis.
• To improve the detection of differential DNA methylation in subsets of individuals within heterogeneous datasets.
• To extend epigenetic analysis to diverse genomic elements, including coding genes, enhancers, and non-coding RNAs.

Main Methods:

• Development of an end-to-end analytical framework named EpiMix.
• Application of EpiMix for population-level analysis of DNA methylation and gene expression.
• Extension of EpiMix to analyze cis-regulatory elements, enhancers, microRNAs, and long non-coding RNAs (lncRNAs).

Main Results:

• EpiMix demonstrated higher sensitivity than existing methods in detecting abnormal DNA methylation in small patient subsets.
• The framework successfully identified epigenetic mechanisms underlying childhood food allergy.
• Survival-associated, methylation-driven non-coding RNAs (ncRNAs) in non-small cell lung cancer were discovered.

Conclusions:

• EpiMix provides a sensitive approach for population-level DNA methylation analysis.
• The framework can uncover subtle epigenetic alterations associated with specific diseases.
• EpiMix facilitates the discovery of novel epigenetic biomarkers, such as methylation-driven ncRNAs, for disease insights and potential therapeutic targets.